Excitation and Inhibition of ACTH Secretion Our laboratories are engaged in studies on the pathways involved in ACTH secretion following operative trauma, hmmorrhage and drug administration. We have used dogs with chronic adrenal venous cannulas for these studies and have analysed the corticosteroid content of adrenal venous blood as a direct measure of adrenal cortical function. ACTH activation following operative trauma is dependent upon intact peripheral nerves, with no evidence to support the existence of a 'wound hormone'. Recent studies on hxemorrhage indicate that slow bleeding (no effect on the systemic blood pressure) leads to rapid adrenal cortical activation, even if the animals have undergone spinal cord section and vagotomy. Taken in conjunction with other studies indicating that small doses of cyanide, in amounts which do not result in changes in respiration or blood lactate, result in adrenal activation, the possibility must be considered that anoxia and its side-effects have something to do with olig.emic normotensive activation of pituitary-adrenal secretion.
Experiments which bear on inhibitory factors involved in ACTH secretion are indirect, but difficult to explain without postulating a hormone, opposite in action to CRF, which is produced in the brain. A preparation has been devised in which the entire brain of the dog is removed down to the level of the inferior colliculus, with only the intact pituitary left in situ. Such animals, with complete absence of the hypothalamus, exhibit adrenal cortical hypersecretion which is immediately abolished by hypophysectomy. Pretreatment of animals with dexamethasone for several days prior to brain removal blocks the expected normal operative adrenal cortical response to adrenal vein cannulation, although brain removal in such animals results in rapid hypersecretion. This is interpreted as suggestive evidence for de novo synthesis of ACTH in an ACTH-depleted pituitary. Since it is established that hypothalamic lesions in the proper site prevent ACTH secretion following operative trauma, it is difficult to explain hypersecretion in animals with removal of the CRF area plus other brain tissue without suggesting the existence of an inhibitory hormone produced in the brain, which normally acts as a moderator of ACTH release by the pituitary. Removal of both CRF and the postulated inhibitory hormone 'unmasks' the spontaneous activity ofa pituitary which is usually under both excitatory and inhibitory hormonal influences. 
Anatomical and Functional Mapping of Central Neural Input and Feedback Pathways of the Adrenocortical System
We have tried to define the corticosteroid sensitivity of the feedback elements of the adrenocortical system more fully than has been done previously. We also examined the capacity of ACTH itself, and that of a monamine oxidase inhibitor to alter acute responses of the adrenocortical system to noxious stimuli. Dexamethasone, ACTH and iproniazid were found to be very selective inhibitors of acute ACTH release. We took advantage of the discovered selectivity to design a new functional and anatomical combined approach to map the neural input pathways that activate and inhibit corticotrophin releasing factor (CRF secretion). Thirteen different stimuli were used to provoke acute response of the adrenocortical system. In addition, the corticosteroid sensitivity of certain regions of the brain was explored by a stereotaxic microinjection technique. The data have led to the formulation of a new model for the arrangement of the central neural elements and pathways in the adrenocortical system. The new model modifies and extends the 'reset' hypothesis of adrenocortical function. The chief results of this work were the following findings:
(1) Stimuli that provoke CRF secretion activate two different inputs to the adrenocortical systema corticocosteroid-sensitive input and a corticcosteroid-resistant input. Different intensities of a single stimulus can provoke these separate classes of response, as well as causing graded responses within a given input class.
(2) The median eminence and the septal regions of the brain have differing specificities for corticosteroid-sensitive stimuli. CRF secretion following certain stimuli can be blocked by median eminence injections of dexamethasone, whereas the response to other stimuli can be blocked only if the corticosteroid is placed in the septal region. Multiple corticosteroid-sensitive inputs to CRFsecreting neurones appear to be present.
(3) Corticosteroid-resistant responses of the adrenocortical system are conspicuous and involve high threshold pathways. As stimulus strength is increased, these pathways become progressively activated and even supramaximal doses of corticosteroids cannot then suppress CRF release.
(4) Prior treatment with ACTH can inhibit acute CRF release to some but not all stimuli. This inhibition is quite restricted, compared to the universal presence of a corticosteroid-sensitive component in the the responses to all stimuli.
